Events

Recall of Captia VZV IgM Reagent

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by Trinity Biotech.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2014-04-29
  • Event Country
    France
  • Event Source
    ANSM
  • Event Source URL
    https://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/reactif-captia-vzv-igm-trinity-biotech-rappel-de-lot
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    The company ORGENTEC informed the users of the reagent Captia VZV IgM of the recall of a lot .. The users concerned, in France, received the email attached (29/04/2014) (40 ko) .. This information s address to the directors of health establishments and local correspondents of reactovigilance for diffusion to the services concerned.

Device

Captia VZV IgM Reagent
  • Model / Serial
  • Product Description
    in-vitro_medical_device
  • Manufacturer
    Trinity Biotech

Manufacturer

Trinity Biotech